


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.27%
+12.08%
-3.87%
+2.73%
-1.11%
ANAB
AnaptysBio
$47.86
Strengths

Upgraded on attractively valued

Expands stock buyback program

Outperform the market

Earnings are forecast to grow
ANAB Price Performance
$45.69 (+4.75%)
$35.28 (+35.66%)
$20.22 (+136.70%)
$17.93 (+166.93%)
ANAB has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

ANAB overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Outperform the market

Earnings are forecast to grow
![]()
ANAB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ANAB Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
ANAB
AnaptysBio
47.86
-5.15%
KMX
CarMax
47.59
+1.71%
CNM
Core & Main
57.51
+1.88%
SBLK
Star Bulk Carriers
20.51
-0.49%
VICR
Vicor Corporation Co
150.57
+3.61%
What is ANAB current stock price?
What are ANAB stock strengths?
What is ANAB Risk Level?
What is ANAB market cap and volume?
What is ANAB current Stock IQ?
Should I buy ANAB stock right now?
Is ANAB a Strong Buy right now?
What does a 'Strong Buy' rating mean for ANAB?
What does a 'Strong Sell' rating mean for ANAB?
What factors influence ANAB's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.27%
+12.08%
-3.87%
+2.73%
-1.11%
ANAB
AnaptysBio
Current Price
$47.86
ANAB Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Expands stock buyback program

Outperform the market

Earnings are forecast to grow
Recently Viewed
ANAB
AnaptysBio
47.86
-5.15%
KMX
CarMax
47.59
+1.71%
CNM
Core & Main
57.51
+1.88%
SBLK
Star Bulk Carriers
20.51
-0.49%
VICR
Vicor Corporation Co
150.57
+3.61%

ANAB Price Performance
$45.69 (+4.75%)
$35.28 (+35.66%)
$20.22 (+136.70%)
$17.93 (+166.93%)
ANAB Analysts Opinion
ANAB Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Outperform the market

Earnings are forecast to grow
![]()
ANAB Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
ANAB Street Sentiment is extremely bullish and have negative views on the near-term outlook
ANAB has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
ANAB Latest Analysis
Anaptys Files Motion to Dismiss Tesaros Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro a GSK subsidiary. SAN DIEGO Jan. 08 2026 (GLOBE NEWSWIRE) -- AnaptysBio Inc. (Nasdaq: ANAB) a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics filed a partial motion to dismiss Tesaros anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys GSK and TESARO Inc. (Tesaro) regarding th
Thu Jan 8, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ANAB Stock trends
ANAB Stock performance
ANAB Stock analysis
ANAB investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.